- Home
- SSKN vs PALI Comparison
SSKN vs PALI Comparison
Compare SSKN & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- PALI
- Stock Information
- Founded
- SSKN 1989
- PALI 1996
- Country
- SSKN United States
- PALI United States
- Employees
- SSKN N/A
- PALI N/A
- Industry
- SSKN Medical/Dental Instruments
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSKN Health Care
- PALI Health Care
- Exchange
- SSKN Nasdaq
- PALI Nasdaq
- Market Cap
- SSKN 8.9M
- PALI 7.5M
- IPO Year
- SSKN 2005
- PALI N/A
- Fundamental
- Price
- SSKN $1.40
- PALI $0.60
- Analyst Decision
- SSKN Strong Buy
- PALI Strong Buy
- Analyst Count
- SSKN 1
- PALI 2
- Target Price
- SSKN $6.00
- PALI $12.00
- AVG Volume (30 Days)
- SSKN 2.9M
- PALI 539.3K
- Earning Date
- SSKN 11-12-2025
- PALI 11-11-2025
- Dividend Yield
- SSKN N/A
- PALI N/A
- EPS Growth
- SSKN N/A
- PALI N/A
- EPS
- SSKN N/A
- PALI N/A
- Revenue
- SSKN $32,848,000.00
- PALI N/A
- Revenue This Year
- SSKN N/A
- PALI N/A
- Revenue Next Year
- SSKN $9.70
- PALI N/A
- P/E Ratio
- SSKN N/A
- PALI N/A
- Revenue Growth
- SSKN 0.36
- PALI N/A
- 52 Week Low
- SSKN $1.38
- PALI $0.53
- 52 Week High
- SSKN $3.86
- PALI $4.32
- Technical
- Relative Strength Index (RSI)
- SSKN 37.68
- PALI 38.56
- Support Level
- SSKN $1.52
- PALI $0.56
- Resistance Level
- SSKN $1.70
- PALI $0.62
- Average True Range (ATR)
- SSKN 0.39
- PALI 0.04
- MACD
- SSKN -0.05
- PALI 0.00
- Stochastic Oscillator
- SSKN 0.81
- PALI 45.25
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.